Hims & Hers Health: Promising Return Profile (NYSE:HIMS)

mixetto/E+ via Getty Images Introduction Hims & Hers Health (NYSE:HIMS) is a telehealth company which focuses on providing high-quality and easy access healthcare, primarily for stigmatized disorders. The company’s target…

Scientists profile FDA-approved drugs to potentially treat hundreds of genetic disorders — ScienceDaily

Nonsense-mediated RNA decay, or NMD, is an evolutionarily conserved molecular mechanism in which potentially defective messenger RNAs, or mRNAs, are degraded. By reducing errors in gene expression, it serves as…